Evolus Celebrates Fifth Anniversary of Launching its Flagship Product Jeuveau® at the Women’s Wear Daily Beauty CEO Summit
Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its participation in the Women’s Wear Daily (WWD) Beauty CEO Summit.
- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced its participation in the Women’s Wear Daily (WWD) Beauty CEO Summit.
- This summit brings together the leading retailers, marketers, and creative minds across all categories to help prepare for the next phase of global beauty while driving growth and innovation today.
- At the global consumer beauty event, President and Chief Executive Officer David Moatazedi is the first medical aesthetics leader to be a speaker in a conversation with WWD Editor-in-Chief Jenny Fine.
- Today also marks the fifth anniversary since the launch of Evolus’ flagship neurotoxin, Jeuveau®, which is the fastest growing toxin brand in the U.S. for the last three years1.